Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Stockholders' Equity

v3.26.1
Consolidated Statements of Stockholders' Equity - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2023 $ 10,977,922 $ 6,186 $ 77,871,584 $ 877 $ (66,900,725)
Beginning balance, Shares at Dec. 31, 2023   6,186,280      
Stock-based compensation expense 8,140,617   8,140,617    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares   63,176,159      
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs 103,305,752 $ 63,176 103,242,576    
Other comprehensive income (38,125)     (38,125)  
Net Income (Loss) (27,519,886)       (27,519,886)
Ending balance at Dec. 31, 2024 $ 94,866,280 $ 69,362 189,254,777 (37,248) (94,420,611)
Ending balance, Shares at Dec. 31, 2024 69,362,439 69,362,439      
Stock-based compensation expense $ 15,309,924   15,309,924    
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares   57,416,415      
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs 110,077,997 $ 57,417 110,020,580    
Contingently Issuable Common Stock Subject To Vesting Criteria, Shares   4,149,252      
Contingently Issuable Common Stock Subject To Vesting Criteria, Value 4,149 $ 4,149      
Issuance of common stock, stock options exercised 845,468 $ 763 844,705    
Issuance of common stock, stock options exercised, Shares   763,131      
Other comprehensive income 59,050     59,050  
Net Income (Loss) (48,259,189)       (48,259,189)
Ending balance at Dec. 31, 2025 $ 172,903,679 $ 131,691 $ 315,429,986 $ 21,802 $ (142,679,800)
Ending balance, Shares at Dec. 31, 2025 131,691,237 131,691,237